A detailed history of Jane Street Group, LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 37,682 shares of NAUT stock, worth $90,436. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,682
Previous 62,702 39.9%
Holding current value
$90,436
Previous $146,000 26.71%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.24 - $3.08 $56,044 - $77,061
-25,020 Reduced 39.9%
37,682 $107,000
Q2 2024

Aug 14, 2024

BUY
$2.22 - $3.0 $70,922 - $95,841
31,947 Added 103.88%
62,702 $146,000
Q1 2024

May 15, 2024

SELL
$2.41 - $3.18 $52,858 - $69,746
-21,933 Reduced 41.63%
30,755 $90,000
Q4 2023

Feb 14, 2024

BUY
$2.34 - $3.39 $93,108 - $134,888
39,790 Added 308.5%
52,688 $157,000
Q3 2023

Nov 14, 2023

SELL
$2.87 - $3.94 $29,741 - $40,830
-10,363 Reduced 44.55%
12,898 $40,000
Q2 2023

Aug 14, 2023

SELL
$2.21 - $4.52 $22,517 - $46,054
-10,189 Reduced 30.46%
23,261 $90,000
Q1 2023

May 15, 2023

BUY
$1.67 - $2.77 $55,861 - $92,656
33,450 New
33,450 $92,000
Q2 2022

Aug 16, 2022

SELL
$2.64 - $4.84 $43,401 - $79,569
-16,440 Reduced 56.89%
12,459 $34,000
Q1 2022

May 17, 2022

BUY
$3.5 - $5.3 $57,596 - $87,216
16,456 Added 132.25%
28,899 $125,000
Q4 2021

Feb 15, 2022

SELL
$4.45 - $6.21 $2,296 - $3,204
-516 Reduced 3.98%
12,443 $65,000
Q3 2021

Nov 16, 2021

SELL
$6.14 - $10.1 $986,962 - $1.62 Million
-160,743 Reduced 92.54%
12,959 $80,000
Q2 2021

Aug 16, 2021

BUY
$9.04 - $14.19 $1.57 Million - $2.46 Million
173,702 New
173,702 $1.75 Million

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $299M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.